
Hodgkin lymphoma is a lymphatic malignancy. The lymphatic system is part of the body's immune system, which fights germs and diseases. Hodgkin lymphoma develops when healthy cells in the lymphatic system mutate and expand out of control.
The lymphatic system contains lymph nodes. They are located throughout the body. Most lymph nodes are in the abdomen, groin, pelvis, chest, underarms, and neck.
The lymphatic system contains the spleen, thymus, tonsils, and bone marrow. Hodgkin lymphoma can affect all these locations and other organs in the body.
Hodgkin lymphoma, formerly known as Hodgkin disease, is one of two primary forms of lymphomas. The other is non-Hodgkin's lymphoma.
The most frequent initial symptom of Hodgkin lymphoma is painless enlarged lymph nodes in the neck, underarm, or groin. Additional symptoms include:
There are four classical Hodgkin lymphoma subtypes:
Disease staging assists healthcare providers in determining how advanced the disease is, how quickly it may spread, and which treatments may be most effective. Here are the phases of Hodgkin lymphoma.
Causes
Risk Factors
The following factors can raise the risk of Hodgkin lymphoma:
Complications
Complications of Hodgkin lymphoma (HL) can include:
Here are some preventative tips for Hodgkin Lymphoma (HL):
While these strategies may not ensure prevention, they promote general health and early intervention.
Chemotherapy: This typical Hodgkin lymphoma treatment employs one or more medications to kill or prevent cancer cells from growing. Providers may utilise one or more types of chemotherapies.
Cost Start From USD 800 - USD 6000Explore Options
Radiation therapy: This therapy employs high-powered laser beams to kill cancer cells in afflicted lymph nodes or areas of malignant dissemination. It is frequently used with chemotherapy for early-stage Hodgkin lymphoma treatment.
Immunotherapy: This treatment strengthens your immune system, making it more effective in identifying and eliminating cancer cells. Checkpoint inhibitors are a key immunotherapy treatment for Hodgkin lymphoma.
{immunotherapy}Targeted therapy: It is the employment of medications or other substances to attack cancer cells. This treatment employs laboratory-created antibodies that are linked to chemotherapeutic medicines. They identify and eliminate cancer cells.
Cost Start From USD 5500 - USD 54000Explore Options
Bone Marrow Transplant: A bone marrow transplant, also known as a bone marrow stem cell transplant, involves introducing healthy bone marrow stem cells into the body. These cells restore damaged cells caused by chemotherapy and other treatments. If Hodgkin's lymphoma reappears or does not respond to conventional therapies, a bone marrow transplant may be a viable alternative.
{bmt-autologous}Rehabilitation for Hodgkin Lymphoma (HL) focuses on assisting patients in recovering physically, emotionally, and cognitively during and after therapy. Key rehabilitation options include:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Sharjah, United Arab Emirates
Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-

Dubai, United Arab Emirates
Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing the United Arab Emirates:
Indeed, if detected early, Hodgkin lymphoma is curable and can be cured. Usually, radiation therapy, chemotherapy, or a mix of the two are used as treatments. Particularly for early-stage illnesses, the survival rates in the United Arab Emirates are in line with the global norm.
Usually, radiation therapy, chemotherapy, or a mix of the two are used as treatments. Chemotherapy is the most popular treatment. In more advanced stages or after a recurrence, stem cell transplants may be considered.
According to studies, the 5- and 10-year survival rates for Hodgkin lymphoma in the United Arab Emirates are over 90%. Access to cutting-edge treatment choices, efficient chemotherapy regimens, and early diagnosis all contribute to these results. The nation's state-of-the-art healthcare system largely makes these positive patient outcomes possible.
Non-Hodgkin lymphoma is more prevalent than Hodgkin lymphoma (HL) in the United Arab Emirates. About 20% of the cases were attributed to HL, while the remaining 80% were attributed to NHL, according to a study conducted at a tertiary centre in the United Arab Emirates. This distribution aligns with worldwide patterns, where NHL is more common than HL.
Standard treatment side effects include nausea, hair loss, exhaustion, infections, and organ damage caused by chemotherapy or radiation. Long-term follow-up is required to monitor for any residual effects.
The majority of patients in the United Arab Emirates who receive treatment for Hodgkin lymphoma experience remission and have excellent long-term results. Early diagnosis, efficient chemotherapy treatments like ABVD, and the availability of cutting-edge imaging and interdisciplinary care are all responsible for this. Research has demonstrated that there have been no deaths or relapses during follow-up, demonstrating the efficacy of current treatment approaches.